Crossmark

A new era in the treatment of kidney diseases: NLRP3 inflammasome and cytokine-targeted therapies

Published Online: 2024-11-01

Published Print: 2025-05

Authors

Leventoğlu, Emre https://orcid.org/0000-0002-0504-7911
Bakkaloğlu, Sevcan A.
License Information

Text and Data Mining valid from 2024-11-01

Version of Record valid from 2024-11-01
More Information

Article History

Received: 13 August 2024

Revised: 9 October 2024

Accepted: 10 October 2024

First Online: 1 November 2024

Declarations

:

: The authors declare no competing interests.

Document is current